Magic mushrooms as a treatment for depression took another step toward mainstream acceptance as a venture capital-backed company announced positive results from a psilocybin trial. Compass Pathways’ psilocybin medication was “well-tolerated in healthy volunteers,” a first step in seeking approval to sell the drug, the London-based company reported in a statement. Subjects also reported “positive […]

Know more, do more.

You'll get access to all of our original analysis, exclusive features, and more for just $9.